Table 3.
Effect | Odds Ratio | 95% Confidence Interval | p-value | |
---|---|---|---|---|
Lower | Upper | |||
Medication Management for Patients with Asthma (n=109) | ||||
Main Predictors | ||||
Professional Visibility | 1.09 | 0.70 | 1.70 | 0.74 |
NP-Administration Relations | 1.96 | 1.23 | 3.12 | 0.006b |
NP-Physician Relations | 0.69 | 0.44 | 1.08 | 0.09 |
Independent Practice and Support | 1.13 | 0.76 | 1.67 | 0.55 |
Covariates | ||||
White ratio | 0.67 | 0.43 | 1.02 | 0.07 |
Female ratio | 1.21 | 1.02 | 1.43 | 0.03b |
Practice (reference=Physician practice) | ||||
Community health center | 0.76 | 0.33 | 1.73 | 0.46 |
Hospital-based clinic | 0.47 | 0.23 | 0.96 | 0.04b |
Other | 0.32 | 0.13 | 0.77 | 0.01b |
| ||||
LDL-C Screening for Cardiovascular Disease and Cholesterol Management (n=89) | ||||
Main Predictors | ||||
Professional Visibility | 0.75 | 0.48 | 1.16 | 0.19 |
NP-Administration Relations | 1.09 | 0.64 | 1.87 | 0.75 |
NP-Physician Relations | 0.90 | 0.56 | 1.44 | 0.66 |
Independent Practice and Support | 1.60 | 1.03 | 2.47 | 0.035b |
Covariates | ||||
Female ratio | 0.87 | 0.48 | 1.58 | 0.65 |
Panel ratio | 0.61 | 0.45 | 0.82 | 0.002b |
Practice (reference=Physician office) | ||||
Community health center | 2.00 | 0.92 | 4.37 | 0.09 |
Hospital-based clinic | 1.49 | 0.63 | 3.52 | 0.42 |
Other | 2.64 | 0.89 | 7.87 | 0.07 |
| ||||
Comprehensive Diabetes Care -HbA1c Testing (n=91) | ||||
Main Predictors | ||||
Professional Visibility | 0.77 | 0.56 | 1.05 | 0.09 |
NP-Administration Relations | 1.01 | 0.71 | 1.44 | 0.97 |
NP-Physician Relations | 1.07 | 0.79 | 1.45 | 0.65 |
Independent Practice and Support | 1.12 | 0.84 | 1.49 | 0.43 |
Covariates | ||||
Nonurban | 0.75 | 0.51 | 1.11 | 0.15 |
only covariates with p-value<0.20 from the bivariate analysis are included in the final multivariable fractional logistic regression models. All continuous variables were standardized with mean 0 and standard deviation 1.
significant at 0.05 level